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httpSilver acetate coating promotes early vascularization
of Dacron vascular grafts without inducing host
tissue inﬂammation
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Matthias Glanemann, MD,a Stefan Dold, MD,a Michael D. Menger, MD,b and
Mohammed R. Moussavian, MD,a Homburg/Saar, Germany
Background: Silver acetate is frequently used as an antimicrobial coating of prosthetic vascular grafts. However, the effects
of this coating on the early inﬂammatory and angiogenic host tissue response still remain elusive. Therefore, the aim of the
present in vivo study was to analyze the biocompatibility and vascularization of silver acetate-coated and uncoated
vascular grafts during the initial phase after implantation.
Methods: Two different prosthetic vascular grafts (ie, uncoated Dacron and silver acetate-coated Dacron Silver) were
implanted into the dorsal skinfold chamber of C57BL/6 mice (n [ 8 per group) to study angiogenesis and leukocytic
inﬂammation at the implantation site by means of repetitive intravital ﬂuorescence microscopy over a 14-day period. At
the end of the in vivo experiments, collagen formation, apoptosis, and cell proliferation were analyzed in the newly
developed granulation tissue surrounding the implants by histology and immunohistochemistry.
Results:During the initial 14 days after implantation, Dacron Silver exhibited an improved vascularization, as indicated by
a signiﬁcantly increased functional capillary density compared with Dacron. This was not associated with a stronger
leukocytic inﬂammatory host tissue response to the implants. Moreover, silver acetate coating did not affect collagen
formation, apoptosis, and cell proliferation at the implantation site.
Conclusions: Silver acetate coating of prosthetic vascular grafts improves their early vascularization without inducing
severe inﬂammatory side effects. Accordingly, this material modiﬁcation crucially contributes to an improved incorpora-
tion of the implants into the host tissue, which may decrease the risk of vascular graft infection. (J Vasc Surg
2013;58:1637-43.)
Clinical Relevance: Scientiﬁc ﬁndings about tissue integrity of antibacterial coated vascular grafts are lacking. A risk factor
for prosthetic vascular graft infection seems to be a contamination before complete incorporation of the implant.
Angiogenesis is a mandatory process for incorporation and biocompatibility of synthetic materials. It is an integral factor in
determining the success or failure after implantation in general of alloplastic material. However, the integrity of silver
acetate-coated vascular grafts still remains unknown. Therefore, it was the aim of our study to investigate angiogenesis and
inﬂammation of silver acetate-coated polyester vascular grafts compared with uncoated grafts in an experimental model.In vascular surgery, in situ replacement of vessels with
an autologous vein or cryopreserved graft is preferably per-
formed because of a low infection rate and high patency.1
However, if suitable vessels are lacking, such as in the case
of aortic reconstruction, a prosthetic graft is the only alter-
native to ensure sufﬁcient blood perfusion. Prosthetic grafts
composed of polyethylenterephthalat (Dacron) or polyte-
traﬂuoroethylene exhibit several beneﬁts. They shorten
reconstruction times and reduce the surgical trauma
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://dx.doi.org/10.1016/j.jvs.2013.02.012Moreover, they are basically available in unlimited quanti-
ties, and they can be produced with speciﬁcally deﬁned
properties superior to those of autologous grafts.2,3 Their
drawbacks, however, include the risk of surrounding
erosion even years following surgery and an increased
risk of prosthetic vascular graft infection (PVGI).4,5
Despite ongoing advances in sterile surgical techniques
and routine antibiotic prophylaxis, the frequency of
PVGI remained at 0.5% to 6% over the past 25 years.
Such infections are associated with extensive morbidity
and 12% to 27% mortality.6-8 Furthermore, the increasing
prevalence of resistant bacteria has been associated with
worsened outcomes for patients after surgery.9 Therefore,
various material modiﬁcations are currently discussed as
potential approaches to reduce the risk of PVGI. They
include the antimicrobial coating of the grafts with silver
in the form of ionic silver acetate.10
The chemical and physical properties of silver are well
known in the ﬁeld of inorganic chemistry.11 In its ionic
state, silver exhibits bactericidal and bacteriostatic effective-
ness against all bacteria.10,12 However, the effects of
implanted silver acetate-coated Dacron grafts on the early1637
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remain elusive, although they may determine the risk of
vascular graft infection. In fact, early vascularization is
mandatory for the rapid ingrowth of newly developing
granulation tissue into the grafts, which reduces the risk
of perigraft seroma formation and subsequent infec-
tion.13,14 Moreover, deﬁcient transmural ingrowth of
newly formed microvessels may cause thrombotic graft
occlusion because of an impaired development of neointi-
mal coverage.15
Therefore, the aim of the present study was to investi-
gate the biocompatibility and vascularization of silver
acetate-coated (Dacron Silver) and uncoated (Dacron)
vascular grafts during the initial phase after implantation.
For this purpose, we used the dorsal skinfold chamber
model, which has been frequently used in the past for the
analysis of the in vivo performance of various biomaterials
by means of intravital ﬂuorescence microscopy.16
METHODS
Animals. A total number of 16 C57BL/6 mice (8-12
weeks old; 24-26 g body weight [bw]; Charles River Labo-
ratories GmbH, Sulzfeld, Germany) were used for the
experiments. They were housed one per cage and had
free access to tap water and standard pellet food (Altromin,
Lage, Germany) throughout the study.
All experiments were conducted in accordance with the
German legislation on protection of animals and the
National Institutes of Health (NIH) Guidelines for the
Care and Use of Laboratory Animals (NIH Publication
#85-23 Rev. 1985). They were approved by the local
governmental animal care committee.
Preparation of the dorsal skinfold chamber. The
implantation procedure of the dorsal skinfold chamber
has been described previously in detail.17 In brief, mice
were anesthetized by an intraperitoneal injection of
75 mg/kg bw ketamine hydrochloride (Ketavet; Parke
Davis, Freiburg, Germany) and 25 mg/kg bw dihydrox-
ylidinothiazine hydrochloride (Rompun; Bayer, Leverku-
sen, Germany). Two symmetrical titanium frames were
then implanted on the extended dorsal skinfold of the
animals, so that they sandwiched the double layer of skin.
One layer of skin was completely removed in a circular area
of 15 mm in diameter, and the remaining layers, consisting
of striated panniculus carnosus muscle, subcutaneous
tissue, and cutis were covered with a removable coverslip
incorporated into one of the titanium frames. After the
preparation, the mice were allowed to recover from anes-
thesia and surgery for 48 hours. The animals tolerated the
chamber and its preparation well, as indicated by normal
feeding and sleeping habits.
Implantation of prosthetic vascular grafts. We
implanted samples of two clinically used prosthetic vascular
grafts (ie, Dacron and Dacron Silver; Intergard Knitted
Silver Polyester), kindly provided by Maquet (Rastatt,
Germany), into the dorsal skinfold chamber. According
to the manufacturer Maquet, Dacron Silver is coated on
its external surface with a silver concentration that iseffective under clinical conditions during the ﬁrst 2-3
weeks after implantation. For implantation, the anesthe-
tized mice were placed in right lateral decubital position
on a Plexiglas stage. The coverslip of the chamber was
temporarily removed and a piece of 2 mm2 of either
Dacron or Dacron Silver was carefully placed with the
outer surface onto the striated muscle tissue within the
center of each chamber, taking care to avoid contamina-
tion, mechanical irritation, or damage to the chamber
preparation.
Intravital ﬂuorescence microscopy. For in vivo
microscopic analyses, the anesthetized mice were placed in
right lateral decubital position on a Plexiglas stage and
received an intravenous injection of 0.05 mL 5% ﬂuo-
rescein isothiocyanate-labeled dextran (molecular weight:
150,000Da; Sigma-Aldrich, Taufkirchen, Germany) for the
visualization of the intravascular space and 0.05 mL 1%
rhodamine 6G (Sigma-Aldrich) for the in vivo analysis of
leukocyte-endothelial cell interaction in postcapillary and
collecting venules at the implantation site. Subsequently,
the mice were positioned under a Zeiss Axiotech micro-
scope (Zeiss, Oberkochen, Germany). The epi-illumination
microscopic setup included a 100 Wmercury lamp and ﬁlter
sets for blue (450-490 nm excitation wavelength/520 nm
emission wavelength), green (530-560 nm/580 nm), and
ultraviolet (330-390 nm/430 nm) light. The microscopic
images were recorded by a charge-coupled device video
camera (FK6990; Pieper, Schwerte, Germany) and recor-
ded on DVD (Panasonic AG-7350-SVHS; Matsushita,
Tokyo, Japan) for subsequent off-line evaluation.
Microcirculatory analysis. The microscopic images
were analyzed quantitatively by means of the computer-
assisted image analysis system CapImage (Zeintl, Heidel-
berg, Germany). Angiogenesis was analyzed in eight
different microvascular regions-of-interest ([ROIs]; size:
0.4 mm2), which were directly located at the interface
between the prosthetic vascular grafts and the surrounding
host tissue (Fig 1, A and B). Detailed information about
the extent of vascular ingrowth into the different ROIs
was provided by the quantitative measurement of the
functional capillary density (ie, the length of newly
formed blood-perfused capillaries per observation area
given in cm/cm).17
In four different ROIs in the border zone of the pros-
thetic vascular grafts (ie, in close vicinity to the implanted
material, Fig 1, A and B), we additionally measured
leukocyte-endothelial cell interaction and microhemody-
namics in postcapillary and collecting venules of the host
tissue. For this purpose, rhodamine 6G-stained leukocytes
were classiﬁed according to their interaction with the
vascular endothelium as adherent, rolling, or free-ﬂowing
cells.18 Adherent leukocytes were deﬁned in each vessel
segment as cells that did not move or detach from the endo-
thelial lining within a speciﬁed observation period of 20
seconds and were given as number of cells per square
mm2 of endothelial surface, calculated from the diameter
and length of the vessel segment studied, assuming a cylin-
drical vessel geometry. Rolling leukocytes were deﬁned as
Fig 1. A, Stereomicroscopic overview of a Dacron Silver vascular
graft (2  2  0.35 mm) directly after implantation onto the
striated muscle tissue in the dorsal skinfold chamber of a C57BL/6
mouse. Note that the larger microvessels of the chamber (arterioles
and venules of the striated muscle and subcutaneous tissue) can be
identiﬁed without the use of high-resolution intravital ﬂuorescence
microscopy. B, The density of newly formed blood-perfused
microvessels growing into the implant was measured in eight
different microvascular regions-of-interest (ROIs; red boxes; size:
0.4 mm2), which were directly located at the interface between the
prosthetic vascular graft and the surrounding host tissue. In
addition, four different ROIs in the border zone of the implant,
(ie, in close vicinity to the material [blue boxes]), leukocyte-
endothelial cell interaction, and microhemodynamics were
measured in postcapillary and collecting venules of the host tissue.
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centerline velocity and were given as number of cells per
minute passing a reference point within the microvessel.19
Diameters, centerline red blood cell (RBC) velocity,
volumetric blood ﬂow, and wall shear rate were determined
in those venules, in which leukocyte-endothelial cell interac-
tion was analyzed. Diameters (d) were measured in mm
perpendicularly to the vessel path. Centerline RBC velocity
(v; given in mm/s) was analyzed by the computer-assisted
image analysis system using the line shift method.20 Volu-
metric blood ﬂow was then calculated by the formulaQ ¼ p  (d/2)2  v/1.6 (given in pL/s), where 1.6 repre-
sents the Baker-Wayland factor to correct for the parabolic
velocity proﬁle in microvessels.21 Moreover, wall shear
rate (y) was calculated based on the Newtonian deﬁnition
y ¼ 8  v/d (given in s1).
Experimental protocol. Samples of Dacron (n ¼ 8)
and Dacron Silver (n ¼ 8) were implanted into dorsal skin-
fold chamber of 16 C57BL/6 mice. Intravital ﬂuorescence
microscopic analyses of angiogenesis, leukocyte-endothelial
cell interaction, and microhemodynamics were performed
directly as well as 3, 6, 10, and 14 days after implantation.
At the end of the in vivo experiments, the animals were
sacriﬁced with an overdose of the anesthetic drug, and the
dorsal skinfold chamber preparations with the implants
were carefully excised for further histologic and immuno-
histochemical analyses.
Histology and immunohistochemistry. For light
microscopy, formalin-ﬁxed specimens of the dorsal skin-
fold preparations were embedded in parafﬁn at day 14
after the implantation of the prosthetic vascular grafts. In
addition, 3-mm thick sections were cut and stained with
hematoxylin and eosin according to standard procedures.
Additional sections were stained with Sirius red to detect
collagen ﬁbers within the newly formed granulation tissue
growing into the implants.
For immunohistochemical detection of apoptotic and
proliferating cells, cleaved caspase-3 (casp-3) and prolifer-
ating cell nuclear antigen (PCNA) staining was per-
formed by a rabbit polyclonal anti-casp-3 antibody (1:100;
New England Biolabs, Frankfurt, Germany) and a mouse
monoclonal anti-PCNA antibody (1:100; Dako GmbH,
Hamburg, Germany) as primary antibodies. This was
followed by a biotin-conjugated goat anti-rabbit anti-
body (Abcam; Cambridge, UK) followed by streptavidin-
peroxidase or a horseradish-peroxidase-conjugated goat
anti-mouse antibody (1:200;Dianova,Hamburg,Germany);
3,30 diaminobenzidine was used as chromogen. The sections
were counter-stained with hemalaun and examined by light
microscopy (BX60; Olympus, Hamburg, Germany). Casp-
3-positive and PCNA-positive cells were assessed in nine
high power ﬁelds per section and are given as percentage of
the total number of cells per high power ﬁeld.
Statistics. After testing the data for normal distribu-
tion and equal variance, differences among the groups
were analyzed by an unpaired Student t-test (SigmaStat;
Jandel Corporation, San Rafael, Calif). All values are
expressed as means 6 standard error of the mean. Statis-
tical signiﬁcance was accepted for a P value of <.05.
RESULTS
Vascularization of prosthetic vascular grafts. In
both experimental groups, the prosthetic vascular grafts
induced an angiogenic host tissue response in the dorsal
skinfold chamber. This was characterized by the initial
formation of microvascular sprouts originating from host
venules and capillaries in the border zones of the implants
at day 3 after implantation. During the following days, the
sprouts progressively grew in the surrounding of the grafts
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Fig 2. Intravital ﬂuorescent microscopic images of the border of Dacron (A) and Dacron Silver vascular grafts (B) at
day 14 after implantation into the dorsal skinfold chamber of C57BL/6 mice. Blue light epi-illumination with contrast
enhancement by 5% ﬂuorescein isothiocyanate (FITC)-labeled dextran 150,000 i.v. C, Functional capillary density
(cm/cm2) within the border of Dacron (white bars; n ¼ 8) and Dacron Silver vascular grafts (black bars; n ¼ 8), as
assessed by intravital ﬂuorescence microscopy and computer-assisted image analysis. Means 6 standard error of the
mean (SEM). *P < .05 vs Dacron at corresponding time points.
Table. Diameter (mm), centerline RBC velocity (mm/s), volumetric blood ﬂow (pL/s), and wall shear rate (s1) of
postcapillary and collecting venules within the border zones of Dacron (n ¼ 8) and Dacron Silver vascular grafts (n ¼ 8)
directly (d0) as well as 3, 6, 10, and 14 days after implantation into dorsal skinfold chambers of C57BL/6 mice.
Mean 6 SEM
d0 d3 d6 d10 d14
Diameter, mm
Dacron 26.2 6 1.0 24.8 6 1.6 24.0 6 1.1 25.6 6 1.1 24.5 6 1.1
Dacron Silver 27.0 6 1.5 28.3 6 2.5 25.8 6 1.9 26.6 6 1.8 26.0 6 1.8
Centerline RBC velocity, mm/s
Dacron 165.7 6 20.8 299.9 6 22.2 308.4 6 28.9 283.4 6 32.3 225.1 6 43.7
Dacron Silver 150.1 6 26.8 250.7 6 9.6 283.9 6 17.9 321.2 6 22.9 311.8 6 20.0
Volumetric blood ﬂow, pL/s
Dacron 58.8 6 11.4 92.0 6 13.0 91.1 6 18.0 94.9 6 19.3 67.6 6 18.3
Dacron Silver 62.1 6 17.3 103.3 6 16.5 97.6 6 14.9 120.2 6 21.9 103.5 6 19.9
Shear rate, s1
Dacron 50.5 6 5.3 98.8 6 8.0 103.6 6 7.3 88.5 6 7.6 74.2 6 12.9
Dacron Silver 51.9 6 10.7 75.6 6 8.3 86.6 6 9.0 98.1 6 7.4 94.9 6 6.9
RBC, Red blood cell; SEM, standard error of the mean.
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and B). In contrast, there was a lack of vascularization in
the center of the vascular grafts throughout the observation
period of 14 days. Importantly, angiogenesis and graft
vascularization were more pronounced in the Dacron Silver
group, which exhibited a signiﬁcantly increased functional
capillary density in the border zones at days 3, 6, 10, and
14 compared with the uncoated Dacron group (Fig 2, C).
Microhemodynamics at the implantation site.
Venules in direct vicinity of the vascular grafts exhibited
a diameter of 24-28 mm (Table). The RBC velocity
within these vessels ranged between 150 and 320 mm/s
throughout the observation period. Accordingly, calculated
values of volumetric blood ﬂow and shear rate were59-120 pL/s and 51-104 s1 (Table). There were no
signiﬁcant differences among the experimental groups,
indicating comparable microhemodynamic conditions for
the analysis of leukocyte-endothelial cell interaction as
a parameter for the inﬂammatory host tissue response to the
implants.
Inﬂammatory response. Throughout the observation
period, numbers of rolling and adherent leukocytes in post-
capillary and collecting venules ranged between 4 to 8
min1 and 91 to 218 mm2 without marked differences
between the Dacron and the Dacron Silver group (Fig 3,
A and B). These values are typical for a physiological
leukocyte-endothelial cell interaction in noninﬂamed tissue
within the dorsal skinfold chamber.17,18
Fig 4. Hematoxylin-eosin stained cross sections of the border zone
of a Dacron Silver vascular graft (asterisk) at day 14 after implan-
tation onto the striated muscle tissue (A, arrows) within the dorsal
skinfold chamber of a C57BL/6 mouse. Higher magniﬁcation
(B) of the interface between the implant and the surrounding tissue
(A, black window) shows the dense vascularization and ingrowth of
a ﬁbrovascular tissue in between the Dacron ﬁbers.
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Fig 3. Rolling leukocytes (A, min1) and adherent leukocytes
(B, mm2) in postcapillary and collecting venules within the
border zones of Dacron (white bars; n ¼ 8) and Dacron Silver
vascular grafts (black bars; n ¼ 8), as assessed by intravital ﬂuo-
rescence microscopy and computer-assisted image analysis.
Means 6 standard error of the mean (SEM). *P < .05 vs Dacron
at corresponding time points.
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tions of the dorsal skinfold chamber preparations at day
14 revealed that Dacron and Dacron Silver grafts were sur-
rounded by a newly formed vascularized granulation tissue.
This tissue grew in between the Dacron ﬁbers (Fig 4, A
and B), promoting the incorporation of the grafts at the
implantation site.
Collagen formation, regeneration, and apoptosis.
Sirius red staining proved collagen formation between the
Dacron ﬁbers without any differences between the two
groups (Fig 5, A and B). Immunohistochemical detection
of PCNA and casp-3 further revealed 11% to 15% prolif-
erating cells and 1% to 2% apoptotic cells in the newly
formed granulation tissue without signiﬁcant differences
between the two groups (Fig 5, C-H).
DISCUSSION
A rapid and adequate vascularization of vascular
prostheses during the early healing process is essential for
the prevention of perioperative or late graft infection.14
In the present study, we demonstrate that this can be
achieved by coating Dacron grafts with silver acetate,
which markedly promotes angiogenesis at the implantation
site without inducing host tissue inﬂammation.
For our experiments, we used the dorsal skinfold
chamber model, which has already been proven to be suit-
able for testing the in vivo performance of prosthetic
vascular grafts.14 By means of intravital ﬂuorescence micros-
copy, this chronic model allows for the repetitive analysis
of the early inﬂammatory and angiogenic host tissue
response to biomaterials during the initial 2-3 weeks
after implantation.16 Thus, in contrast to simple histologic
approaches, the dorsal skinfold chamber model providesa direct in vivo insight into the dynamic interaction of the
implants with the surrounding tissue.
Silver acetate is a hydrophilic cation with redox activity.
It has the ability to interact with other ions that can alter
human and bacterial cellular functions, cell metabolism,
or biological functions, by binding to macromolecules
such as membrane phospholipids, lysosomal enzymes,
and nucleic acids, as well as by activating ion channels or
secondary signaling pathways.22 Accordingly, silver acetate
is commonly used as a coating for Dacron grafts to prevent
vascular graft infection. However, the effects of this type
of coating on the engraftment of the implants are still
a matter of debate.23,24
Of interest, we herein found that silver acetate coating
stimulates the ingrowth of new microvessels into Dacron
vascular grafts. This may be explained by direct proangio-
genic effects of silver. In fact, Kang et al25 recently reported
that silver nanoparticles induce tube formation on growth
factor-reduced Matrigel, production of reactive oxygen
species and release of the angiogenic factors vascular
endothelial growth factor and nitric oxide by endothelial
SVEC4-10 cells. Because there is a chemical balance
between the elementary and ionic state of silver under
in vivo conditions, some of the observed effects of silver
nanoparticles may be also transferable to ionic silver
acetate.26 On the other hand, it is well known that inﬂam-
mation is a major stimulus for the development of new
blood vessels.17 However, in the present study, we did
not detect an increased leukocytic inﬂammatory host tissue
response to Dacron Silver grafts. In both experimental
groups (ie, Dacron and Dacron Silver), the numbers of roll-
ing and adherent leukocytes in venules of the implantation
Fig 5. Histologic cross-sections of the border zones of a Dacron (A, C, E) and a Dacron Silver vascular graft (B, D, F)
at day 14 after implantation onto the striated muscle tissue within the dorsal skinfold chambers of C57BL/6 mice. The
sections were stained with Sirius red (A and B) for the visualization of collagen ﬁbers or antibodies against proliferating
cell nuclear antigen (PCNA) (C and D) and caspase-3 (casp-3) (E and F) for the detection of proliferating and
apoptotic cells. PCNA-positive cells (G, %) and casp-3-positive cells (H, %) in the border zones of Dacron (white bars;
n ¼ 8) and Dacron Silver vascular grafts (black bars; n ¼ 8) at day 14. Means 6 standard error of the mean (SEM).
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conditions in the dorsal skinfold chamber model.17,18
Besides vascularization, we also analyzed collagen forma-
tion, cell proliferation, and apoptotic cell death within the
newly formed granulation tissue surrounding the implants
at day 14. We did not detect marked differences between
the groups of uncoated and silver acetate-coated vascular
grafts. This is an important ﬁnding considering the fact
that higher concentrations of silver have been shown to be
cytotoxic and to induce apoptosis.23 However, such concen-
trations seem not to be released from the Dacron Silver
grafts, indicating that these prostheses exhibit a good
biocompatibility. This view is further supported by our
ﬁnding that a ﬁbrovascular granulation tissue grew in
between the Dacron ﬁbers of the implants throughout
the observation period, promoting their incorporation at
the implantation site. This is a major prerequisite for the
durability and resistance of the implants to infection and
rejection following surgery.13,27 In fact, ﬁbroblasts and ﬁbro-
cytes are strongly involved in the perigraft healing process.
These cells cover the surface of the grafts and protect them
before they can be colonized by bacteria.28 However, we
did not detect an increased collagen formation around the
ﬁbers of the Dacron Silver grafts compared with uncoatedgrafts, although they exhibited an improved vascularization.
This may be due to the early observation time point of 14
days postimplantation, where the incorporation of the grafts
was still not completed. On the other hand, a previous
study analyzing the incorporation of different surgical
mesh types in the dorsal skinfold chamber could demonstrate
that vascularization does not necessarily show a positive
correlation to collagen formation within the implants.29
CONCLUSIONS
Taken together, silver acetate coating of prosthetic
vascular grafts improves their vascularization after implan-
tation without inducing severe inﬂammatory side effects.
Thus, besides its antimicrobial properties, this material
modiﬁcation is also suitable to promote the early host tissue
incorporation of the implants.
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